Back to Journals » Drug Design, Development and Therapy » Volume 17

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn’s Disease: Patient Selection and Reported Outcomes

Total article views   HTML views PDF downloads Totals
10,395 Dovepress* 4,604+ 118 4,722
PubMed Central* 5,791 582 6,373
Totals 10,395 700 11,095
*Since 31 January 2023
Total mentioned Facebook Delicious Reddit Twitter Others
16 0 0 0 8 8

View citations on PubMed Central and Google Scholar